Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinicaβ¦
ISININE579C01029
Listedβ
Quarters tracked13
Filings20 docs
Market Price
OpenHighLowPrev Close
Price unavailable
About
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap2,834 Cr
P/E46.60
Div Yield0.31 %
Book ValueβΉ77.20
52w HighβΉ903.00
52w LowβΉ376.00
Face ValueβΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Mar 2022
Dec 2021
Sales
90.00
85.00
75.00
80.00
75.00
66.00
83.00
82.00
77.00
80.00
79.00
74.00
67.00
Expenses
57.00
55.00
49.00
55.00
51.00
48.00
59.00
58.00
56.00
54.00
55.00
51.00
47.00
Operating Profit
33.00
30.00
26.00
24.00
24.00
17.00
25.00
24.00
21.00
25.00
24.00
23.00
21.00
OPM %
37.00
35.00
35.00
31.00
32.00
27.00
30.00
30.00
28.00
32.00
30.00
31.00
31.00
Other Income
5.00
-1.00
-1.00
0.00
-1.00
0.00
1.00
1.00
1.00
1.00
1.00
0.00
1.00
Depreciation
10.00
8.00
8.00
8.00
8.00
9.00
8.00
8.00
8.00
8.00
7.00
7.00
6.00
Interest
1.00
0.00
0.00
1.00
1.00
1.00
0.00
0.00
1.00
1.00
1.00
1.00
0.00
Profit before tax
28.00
20.00
17.00
16.00
14.00
8.00
16.00
17.00
14.00
18.00
17.00
16.00
15.00
Tax %
23.00
24.00
26.00
24.00
25.00
25.00
25.00
23.00
27.00
26.00
28.00
27.00
25.00
Net Profit
22.00
15.00
12.00
12.00
10.00
6.00
12.00
13.00
10.00
13.00
12.00
12.00
12.00
EPS in Rs
4.84
3.44
2.77
2.79
2.29
1.43
2.75
2.86
2.32
2.99
2.72
2.68
2.64
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Sales
318.00
318.00
278.00
211.00
181.00
Expenses
231.00
223.00
198.00
158.00
151.00
Operating Profit
87.00
95.00
80.00
53.00
30.00
OPM %
27.00
30.00
29.00
25.00
17.00
Other Income
4.00
3.00
0.00
1.00
3.00
Interest
2.00
3.00
2.00
2.00
4.00
Depreciation
34.00
31.00
23.00
23.00
21.00
Profit before tax
54.00
65.00
56.00
29.00
8.00
Tax %
25.00
26.00
26.00
25.00
17.00
Net Profit
41.00
48.00
41.00
21.00
7.00
EPS in Rs
9.26
10.87
9.35
4.84
1.55
Dividend Payout %
11.00
9.00
11.00
21.00
0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Sep 2024
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Equity Capital
4.00
4.00
4.00
4.00
4.00
4.00
Reserves
338.00
315.00
277.00
230.00
190.00
168.00
Borrowings
12.00
19.00
15.00
19.00
30.00
33.00
Other Liabilities
86.00
61.00
65.00
54.00
50.00
40.00
Total Liabilities
440.00
400.00
362.00
307.00
274.00
246.00
Fixed Assets
183.00
171.00
175.00
169.00
135.00
138.00
CWIP
75.00
59.00
12.00
0.00
17.00
2.00
Investments
0.00
0.00
0.00
0.00
0.00
0.00
Other Assets
183.00
170.00
175.00
138.00
122.00
106.00
Total Assets
440.00
400.00
362.00
307.00
274.00
246.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Cash from Operating Activity
61.00
88.00
59.00
37.00
24.00
Cash from Investing Activity
-76.00
-57.00
-38.00
-32.00
-21.00
Cash from Financing Activity
-2.00
-11.00
-17.00
-5.00
-1.00
Net Cash Flow
-17.00
20.00
5.00
1.00
3.00
Free Cash Flow
-14.00
38.00
20.00
4.00
9.00
CFO/OP %
88.00
106.00
94.00
84.00
102.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Debtor Days
100.00
92.00
101.00
127.00
117.00
Inventory Days
185.00
187.00
115.00
140.00
191.00
Days Payable
62.00
119.00
82.00
142.00
117.00
Cash Conversion Cycle
223.00
159.00
134.00
125.00
191.00
Working Capital Days
89.00
76.00
86.00
86.00
64.00
ROCE %
18.00
25.00
24.00
14.00
β
Shareholding Pattern
% holding β latest first
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
35.66
35.85
35.89
35.99
36.67
36.70
36.76
36.89
36.89
36.92
36.98
37.00
FIIs
4.41
4.89
4.59
4.33
3.49
3.66
3.81
3.31
5.16
5.13
2.88
2.74
DIIs
0.37
0.13
0.11
0.87
1.42
1.43
1.15
0.00
1.49
1.50
1.49
1.50
Public
59.55
59.12
59.40
58.80
58.42
58.20
58.28
59.80
56.45
56.45
58.65
58.75
No. of Shareholders
50,190
51,623
54,467
55,933
30,829
26,183
21,156
20,114
19,054
18,550
19,957
18,429
Corporate Actions
25 records
Action
Ex Date
Record Date
Ratio
Amount (βΉ)
Notes
Dividend
18 Jun 2026
18 Jun 2026
β
2.00
Bonus
13 Jun 2025
13 Jun 2025
1:1
β
Dividend
30 May 2025
30 May 2025
β
2.00
Dividend
11 Jul 2024
β
β
2.00
Dividend
21 Jun 2023
β
β
2.00
Dividend
16 Jun 2022
18 Jun 2022
β
2.00
Dividend
25 Jun 2021
28 Jun 2021
β
2.00
Other
01 Sep 2020
β
β
β
Annual General Meeting
Dividend
18 Jul 2019
β
β
2.00
Dividend
14 Aug 2018
β
β
2.00
Other
19 Sep 2017
β
β
β
Annual General Meeting
Dividend
25 Aug 2016
β
β
1.00
Dividend
06 Aug 2015
β
β
1.00
Dividend
27 Jun 2014
β
β
2.00
Dividend
23 May 2013
β
β
0.60
Other
23 May 2013
β
β
β
Annual General Meeting / Final Dividend Re.0.60/- Per Equity Share